Medication-related osteonecrosis of the jaw (Q67496): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/1143080357 / rank | |||
Normal rank | |||
Revision as of 15:19, 14 August 2026
Patients may be considered to have MRONJ (medication-related osteonecrosis of the jaw) if all of the following characteristics are present: 1. Current or previous treatment with antire-sorptive or antiangiogenic agents; 2. Exposed bone or bone that can be probed through an intraoral or extraoral fistula(e) in the maxillofacial region that has persisted for more than eight weeks; 3. No history of radiation therapy to the jaws or obvious metastatic disease to the jaws.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1143080357 |
||
| English | Medication-related osteonecrosis of the jaw |
Patients may be considered to have MRONJ (medication-related osteonecrosis of the jaw) if all of the following characteristics are present: 1. Current or previous treatment with antire-sorptive or antiangiogenic agents; 2. Exposed bone or bone that can be probed through an intraoral or extraoral fistula(e) in the maxillofacial region that has persisted for more than eight weeks; 3. No history of radiation therapy to the jaws or obvious metastatic disease to the jaws. |
